Blancafort Pilar
Blancafort Pilar
The Harry Perkins Institute of Medical Research, University of Western Australia
Verified email at
Cited by
Cited by
Epigenetic reprogramming of cancer cells via targeted DNA methylation
AG Rivenbark, S Stolzenburg, AS Beltran, X Yuan, MG Rots, BD Strahl, ...
Epigenetics 7 (4), 350-360, 2012
Breastmilk is a novel source of stem cells with multilineage differentiation potential
F Hassiotou, A Beltran, E Chetwynd, AM Stuebe, AJ Twigger, P Metzger, ...
Stem cells 30 (10), 2164-2174, 2012
Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy
Y Wang, H Su, Y Yang, Y Hu, L Zhang, P Blancafort, L Huang
Molecular Therapy 21 (2), 358-367, 2013
Development of zinc finger domains for recognition of the 5′-CNN-3′ family DNA sequences and their use in the construction of artificial transcription factors
B Dreier, RP Fuller, DJ Segal, CV Lund, P Blancafort, A Huber, B Koksch, ...
Journal of Biological Chemistry 280 (42), 35588-35597, 2005
Evaluation of a modular strategy for the construction of novel polydactyl zinc finger DNA-binding proteins
DJ Segal, RR Beerli, P Blancafort, B Dreier, K Effertz, A Huber, B Koksch, ...
Biochemistry 42 (7), 2137-2148, 2003
Designing transcription factor architectures for drug discovery
P Blancafort, DJ Segal, CF Barbas
Molecular pharmacology 66 (6), 1361-1371, 2004
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
S Stolzenburg, MG Rots, AS Beltran, AG Rivenbark, X Yuan, H Qian, ...
Nucleic acids research 40 (14), 6725-6740, 2012
Scanning the human genome with combinatorial transcription factor libraries
P Blancafort, L Magnenat, CF Barbas III
Nature biotechnology 21 (3), 269-274, 2003
Hallmarks of cancer: The CRISPR generation
C Moses, B Garcia-Bloj, AR Harvey, P Blancafort
European Journal of Cancer 93, 10-18, 2018
Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA
JA Kretzmann, D Ho, CW Evans, JHC Plani-Lam, B Garcia-Bloj, ...
Chemical science 8 (4), 2923-2930, 2017
Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors
A Beltran, S Parikh, Y Liu, BD Cuevas, GL Johnson, BW Futscher, ...
Oncogene 26 (19), 2791-2798, 2007
Generation of tumor-initiating cells by exogenous delivery of OCT4transcription factor
AS Beltran, AG Rivenbark, BT Richardson, X Yuan, H Quian, JP Hunt, ...
Breast cancer research 13 (5), 1-21, 2011
Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer
S Stolzenburg, AS Beltran, T Swift-Scanlan, AG Rivenbark, R Rashwan, ...
Oncogene 34 (43), 5427-5435, 2015
Gene expression in breastmilk cells is associated with maternal and infant characteristics
AJ Twigger, AR Hepworth, C Tat Lai, E Chetwynd, AM Stuebe, ...
Scientific reports 5 (1), 12933, 2015
Zinc fingers, TALEs, and CRISPR systems: a comparison of tools for epigenome editing
CB Waryah, C Moses, M Arooj, P Blancafort
Epigenome editing: methods and protocols, 19-63, 2018
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ...
NPJ precision oncology 4 (1), 24, 2020
Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function
AS Beltran, LM Graves, P Blancafort
Oncogene 33 (39), 4767-4777, 2014
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system
B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ...
Oncotarget 7 (37), 60535, 2016
Activating PTEN tumor suppressor expression with the CRISPR/dCas9 system
C Moses, F Nugent, CB Waryah, B Garcia-Bloj, AR Harvey, P Blancafort
Molecular Therapy-Nucleic Acids 14, 287-300, 2019
Cisplatin induces differentiation of breast cancer cells
P Prabhakaran, F Hassiotou, P Blancafort, L Filgueira
Frontiers in oncology 3, 134, 2013
The system can't perform the operation now. Try again later.
Articles 1–20